According to our findings, the cisplatin-resistant ovarian cancer cell line, OVCAR8, exhibited higher expression levels of TRPML1 compared to both the cisplatin-sensitive cancer cell line (TOV21G) and non-cancerous cells. The gene discussed is MCOLN1; the disease is ovarian carcinoma.